What is Savara's debt repayments?

Savara (SVRA) reported debt repayments of $27.23M in Q1 2025.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Savara SVRA Debt Repayments

Debt Repayments at other companies

Innoviva, Inc.INVA

$0—

Zevra Therapeutics, Inc.ZVRA

$60.09M—

ANI PharmaceuticalsANIP

$4.06M+100%

United TherapeuticsUTHR

$0-100%

LQD

Liquidia CorporationLQDA

$19.97M+841%

AdaptHealthAHCO

$14.06M-43.7%

Other financials

Income statement

See full

Revenue-—

Operating income-$39.0M-37.1%

Net income-$37.3M-40.0%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$38.8M+98.4%

Total debt$30.1M+1.8%

Total equity$176.0M+19.1%

Total assets$221.6M+17.1%

Cash flow

See full

Operating cash flow-$33.0M-21.5%

CapEx$54.0K+1,700%

Free cash flow-$33.1M-21.7%

Valuation

See full

Market cap$1.24B+247%

Enterprise value$1.23B+235%

P/S4,808.2×—

Profitability

See full

Operating margin-19,183.3%—

Net margin-19,305.1%—

FCF margin-15,518.7%—

Returns & leverage

See full

Return on equity-80%+4.7pp

Debt / equity0.2×0.0×

Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Savara's debt repayments?: Savara (SVRA) reported debt repayments of $27.23M in Q1 2025.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.